Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | APP | P05067 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodomethane SCHEMBL4054071 | 0.96 | CYP1A2 (0.63) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| SCHEMBL9190961 | 0.92 | CYP1A2 (0.58) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| SCHEMBL2170339 | 0.89 | CYP1A2 (0.55) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| SCHEMBL13862753 | 0.86 | NPC1 (0.56) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| SCHEMBL25250383 | 0.85 | TDP1 (0.55) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| Hydrochlorthiazide SCHEMBL9735331 | 0.85 | CYP1A2 (0.51) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| SCHEMBL31276816 | 0.85 | NPC1 (0.55) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| SCHEMBL95067 | 0.85 | NPC1 (0.55) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| SCHEMBL2172527 | 0.84 | TDP1 (0.57) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 | |
| SCHEMBL19850971 | 0.84 | TDP1 (0.64) | CYP1A2CYP3A4CYP2C19TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4441112-A1 | METHOD OF UNDERWATER BONDING | Henkel AG & Co. KGaA (DE) | 2024-10-09 | — | — | EP | claimed |
| US-20240318052-A1 | METHOD OF UNDERWATER BONDING | HENKEL AG & CO KGAA (DE) | 2024-09-26 | — | — | US | claimed |
| CN-117447463-A | Preparation and application of stable isotope labeled PBB3 compound | 深圳鼎邦生物科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| WO-2023099777-A1 | METHOD OF UNDERWATER BONDING | Henkel IP & Holding GmbH (DE) | 2023-06-08 | — | — | WO | claimed |
| CN-113402513-A | Stability isotope labeled PM-PBB3 compound and preparation and application methods thereof | 深圳鼎邦生物科技有限公司 | 2021-09-17 | — | — | CN | claimed |
| CN-109476874-B | Two-part cyanoacrylate curable adhesive systems | 汉高知识产权控股有限责任公司 | 2021-04-16 | — | — | CN | claimed |
| EP-1087952-B1 | BENZAZOLE COMPOUNDS AND THEIR USE | NOVARTIS AG (CH) | 2004-06-02 | — | — | EP | claimed |
| US-6410578-B1 | INSECTICIDE, MITICIES, PESTICIDE | NOVARTIS ANIMAL HEALTH US, INC. | 2002-06-25 | — | — | US | claimed |
| EP-1087952-A1 | BENZAZOLE COMPOUNDS AND THEIR USE | Novartis AG (CH) | 2001-04-04 | — | — | EP | claimed |
| WO-1999065886-A1 | BENZAZOLE COMPOUNDS AND THEIR USE | NOVARTIS AG (CH) | 1999-12-23 | — | — | WO | claimed |
| EP-0318294-B1 | Dimeric and trimeric cationic dyes | NIPPON CHEMICAL WORKS (JP) | 1994-12-28 | — | — | EP | claimed |
| EP-0318294-A2 | Dimeric and trimeric cationic dyes | NIPPON CHEMICAL WORKS CO., LTD (JP) | 1989-05-31 | — | — | EP | claimed |
| JP-4018094-A | — | — | None | — | — | JP | disclosed |
| US-12559486-B2 | Tau-protein targeting compounds and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250340547-A1 | NOVEL COMPOUNDS FOR IMAGING TAU PROTEINS THAT ACCUMULATE IN THE BRAIN | NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) | 2025-11-06 | — | — | US | disclosed |
| CN-119954801-A | TAU protein targeting compounds and related methods of use | 阿尔维纳斯运营股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-0383092-A2 | Chromogenic merocyanine enzyme substrates | Bayer Corporation (US) | 1990-08-22 | — | — | EP | disclosed |
| US-4861897-A | 2-Aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0318294-A2 | Dimeric and trimeric cationic dyes | NIPPON CHEMICAL WORKS CO., LTD (JP) | 1989-05-31 | — | — | EP | disclosed |
| US-4826833-A | ANTIBIOTICS | PFIZER INC. (US) | 1989-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559486-B2 | Tau-protein targeting compounds and associated methods of use | UBQLN2, UBQLN1, CRBN | CYP1A2 4771/4885CYP3A4 4658/4885CYP2C19 4854/4885 |
| US-20250340547-A1 | NOVEL COMPOUNDS FOR IMAGING TAU PROTEINS THAT ACCUMULATE IN THE BRAIN | MAPT, FABP7, HTT | CYP1A2 2975/4885CYP3A4 3570/4885CYP2C19 4555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.